Published in Pharm Res on September 11, 2008
Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov (2010) 1.73
Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice. Drug Metab Dispos (2011) 0.90
Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null mice. J Pharm Sci (2010) 0.81
Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption. J Biomed Sci (2010) 0.75
In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation. Pharm Res (2017) 0.75
Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm (2003) 1.26
Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm (2007) 1.20
Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release (2006) 1.15
Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin. Drug Metab Dispos (2002) 1.03
Gastrointestinal transit and drug absorption. Biol Pharm Bull (2002) 1.01
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. J Control Release (2006) 0.99
Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm (2004) 0.97
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Int J Pharm (2011) 0.96
Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Control Release (2004) 0.94
Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int J Pharm (2007) 0.93
Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int J Pharm (2006) 0.92
Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells. Pharm Res (2003) 0.92
Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int J Pharm (2006) 0.91
Interaction of polyphenols with proteins: binding of (-)-epigallocatechin gallate to serum albumin, estimated by induced circular dichroism. Chem Pharm Bull (Tokyo) (2009) 0.91
In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells. J Control Release (2008) 0.90
Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int J Pharm (2008) 0.89
Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int J Pharm (2008) 0.88
In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release (2008) 0.86
Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor. J Control Release (2004) 0.86
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Release (2005) 0.86
Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB gene. Arthritis Res Ther (2006) 0.85
Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. J Control Release (2004) 0.82
Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. Int J Pharm (2002) 0.82
Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug. Int J Pharm (2007) 0.81
Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. J Control Release (2003) 0.81
Pharmacokinetics and safety of resveratrol derivatives in humans after oral administration of melinjo (Gnetum gnemon L.) seed extract powder. J Agric Food Chem (2014) 0.80
Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers. Int J Pharm (2002) 0.80
Effects of temperature, growth phase and luxO-disruption on regulation systems of toxin production in Vibrio vulnificus strain L-180, a human clinical isolate. World J Microbiol Biotechnol (2013) 0.79
Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide. Biol Pharm Bull (2006) 0.79
Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers. Int J Pharm (2008) 0.79
Transport of D-glucose across cultured stratified cell layer of human oral mucosal cells. J Pharm Pharmacol (2002) 0.79
Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function. Pharm Res (2007) 0.79
Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I. Biol Pharm Bull (2012) 0.79
Regulation of drug absorption from small intestine by enteric nervous system I: a poorly absorbable drug via passive diffusion. Drug Metab Pharmacokinet (2004) 0.79
Involvement of intracellular Ca2+ dynamics in cytoprotective action by amino acids and cytotoxicity by sodium laurate, an absorption enhancer. J Pharm Sci (2006) 0.79
Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. J Pharm Sci (2003) 0.79
Deeper penetration into tumor tissues and enhanced in vivo antitumor activity of liposomal paclitaxel by pretreatment with angiogenesis inhibitor SU5416. Mol Pharm (2012) 0.78
Interaction of polyphenolic metabolites with human serum albumin: a circular dichroism study. Chem Pharm Bull (Tokyo) (2009) 0.78
Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points. Int J Pharm (2004) 0.78
In vitro evaluation of the ciliary beat frequency of the rat nasal epithelium using a high-speed digital imaging system. Biol Pharm Bull (2013) 0.78
Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium. J Pharm Sci (2002) 0.78
Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (Gita) model. Drug Metab Pharmacokinet (2002) 0.77
Important role of serum proteins associated on the surface of particles in their hepatic disposition. J Control Release (2002) 0.77
Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids. J Control Release (2006) 0.77
Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol. Parasitol Int (2011) 0.77
Animal models for predicting potency of oral sustained-release adhesive microspheres in humans. Int J Pharm (2006) 0.77
Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion. J Pharm Sci (2014) 0.77